halofuginone has been researched along with Malaria in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Gill, J; Sharma, A | 1 |
Clardy, J; Derbyshire, ER; Mazitschek, R | 1 |
Bronze, MR; da Cruz, FP; Gamo, FJ; Gonçalves, D; Gut, J; Lafuente-Monasterio, MJ; Lopes, F; Moreira, R; Mota, MM; Prudêncio, M; Ressurreição, AS; Rodrigues, T; Rosenthal, PJ; Schneider, G; Sitoe, AR | 1 |
1 review(s) available for halofuginone and Malaria
Article | Year |
---|---|
Prospects of halofuginone as an antiprotozoal drug scaffold.
Topics: Animals; Antiprotozoal Agents; Fibrosis; Humans; Malaria; Piperidines; Quinazolinones | 2022 |
2 other study(ies) available for halofuginone and Malaria
Article | Year |
---|---|
Characterization of Plasmodium liver stage inhibition by halofuginone.
Topics: Animals; Antimalarials; Cell Line, Tumor; Cytokinesis; High-Throughput Screening Assays; Humans; Inhibitory Concentration 50; Liver; Malaria; Mice; Models, Biological; Piperidines; Plasmodium berghei; Plasmodium falciparum; Quinazolinones; Sporozoites; Structure-Activity Relationship | 2012 |
Quinolin-4(1H)-imines are potent antiplasmodial drugs targeting the liver stage of malaria.
Topics: Antimalarials; Cell Line, Tumor; Humans; Imines; Liver; Malaria; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Quinolines; Structure-Activity Relationship | 2013 |